Drug Information

Drug General Information
Drug ID
D0Q9HT
Former ID
DIB015849
Drug Name
LY-307161 SR
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Discontinued in Phase 2 [547340]
Company
Eli Lilly & Co
Target and Pathway
Target(s) Glucagon-like peptide 1 receptor Target Info Modulator [526855]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Insulin secretion
Reactome Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
G alpha (s) signalling events
Glucagon-type ligand receptors
WikiPathways GPCRs, Class B Secretin-like
Integration of energy metabolism
GPCR ligand binding
GPCR downstream signaling
References
Ref 547340Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015327)
Ref 526855Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003 Sep;25(7):565-97.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.